无功能垂体腺瘤术后残余:辅助或延迟伽玛刀放射外科治疗
回顾性研究纳入2002至2015年接受手术及伽玛刀放射外科(GKRS)的无功能垂体腺瘤患者50例,按GKRS指征分为辅助组13例(术后≤6个月)与延迟组37例(随访MRI证实进展后)。两组10年肿瘤控制率分别为92%与96%(P=0.408),10年内分泌控制率分别为82%与49%(P=0.597)。结论认为辅助GKRS与延迟GKRS获得同样高的长期肿瘤控制,均未导致额外神经并发症,辅助GKRS有减少额外内分泌缺陷的趋势。
要点
- 辅助组与延迟组10年肿瘤控制率分别为92%与96%(P=0.408)。
- 辅助组与延迟组10年内分泌控制率分别为82%与49%(P=0.597)。
- GKRS相关并发症(瘤内出血和瘤组织炎症)见于6%患者,延迟组4%、辅助组2%。
核心结论
- 辅助GKRS与延迟GKRS获得同样高的长期肿瘤控制。
- 辅助或延迟GKRS均未导致额外神经并发症。
- 辅助GKRS与延迟GKRS相比有减少额外内分泌缺陷的趋势。
研究设计与样本
- 回顾性研究,纳入2002至2015年接受初次手术及GKRS的无功能垂体腺瘤患者。
- 按GKRS指征分为辅助治疗组(术后≤6个月行GKRS)与延迟治疗组(随访MRI证实进展后行GKRS)。
- 共纳入50例,辅助组13例,延迟组37例。
主要发现
- 辅助组与延迟组10年实际肿瘤控制率分别为92%与96%(P=0.408)。
- 辅助组与延迟组10年实际内分泌控制率分别为82%与49%(P=0.597)。
- GKRS后无患者出现新发神经功能缺损。
- GKRS诱发并发症(瘤内出血和瘤组织炎症)见于6%患者,其中延迟组4%、辅助组2%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: It is still not clear whether Gamma Knife radiosurgery (GKRS) for nonfunctional pituitary adenomas should be used as a standard adjuvant postoperative therapy or applied when there is documented progression of the remnant on follow-up magnetic resonance imaging. METHODS: We performed a retrospective study of patients with nonfunctional pituitary adenomas who underwent primary surgery and GKRS between 2002 and 2015. Patients were divided into 2 groups on the basis of the GKRS indication: adjuvant treatment (GKRS ≤6 months postoperatively) or delayed treatment (GKRS if documented progression occurred on the follow-up magnetic resonance imaging). RESULTS: Fifty patients were included and grouped based on adjuvant (n = 13) or delayed (n = 37) GKRS following primary surgery. The adjuvant and delayed groups had 10-year actuarial tumor control rates of 92% and 96% (P = 0.408), respectively. The 10-year actuarial endocrinologic control rate was 82% for the adjuvant group and 49% for the delayed group (P = 0.597). None of the patients developed any new neurologic deficit post-GKRS. GKRS-induced complications (intratumoral bleeding and tumoral tissue inflammation) occurred in 6% of the patients, of whom 4% were in the delayed group and 2% in the adjuvant group. CONCLUSION: Adjuvant treatment with GKRS yields the same high long-term tumor control as delayed GKRS. Neither adjuvant nor delayed GKRS induced additional neurologic complications. There is a trend that adjuvant GKRS induces less additional endocrinologic deficits compared with delayed GKRS.
引用
- Sadik ZHA, Voormolen EHJ, Depauw PRAM, et al. Treatment of Nonfunctional Pituitary Adenoma Postoperative Remnants: Adjuvant or Delayed Gamma Knife Radiosurgery? World Neurosurg. 2017. PMID: 28108427. doi:10.1016/j.wneu.2017.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。